Actively Recruiting

Age: 18Years +
All Genders
ID06764134

Observational Study to Evaluate Postoperative Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON Endostapler Sponsored by University Hospital Heidelberg

Led by University Hospital Heidelberg · Updated on 2025-01-08

110

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the rate of postoperative pancreatic fistula (POPF), a serious complication, following distal pancreatectomy (DP) using the AEON173 Endostapler. This prospective, observational study involves 110 patients undergoing DP at the University of Heidelberg. The study aims to optimize surgical techniques and improve patient outcomes by assessing the occurrence of POPF and other perioperative factors. The study includes patients scheduled for minimally invasive or open distal pancreatectomy, with or without splenectomy or left adrenalectomy, using the AEON173 Endostapler for pancreas stump closure. There are no interventions beyond standard surgical care since this is an observational study. Patients are enrolled after informed consent and monitored for complications and outcomes over time. Participants will be followed up on postoperative days 1, 3, 14, 30, and 90 with evaluations including measurement of amylase levels in drain fluid to detect pancreatic leakage. Researchers will assess the rate of clinically relevant POPF according to established guidelines, as well as other outcomes like blood loss, operation time, ICU and hospital stay length, reoperation rates, and 90-day mortality. Data collected will help inform safer surgical practices and potentially reduce healthcare costs.

CONDITIONS

Official Title

Assessing Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON Endostapler

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older.
  • Ability to understand the nature and consequences of the study.
  • Provision of written informed consent.
  • Scheduled for minimally invasive or open distal pancreatectomy for any indication, with or without splenectomy and/or left adrenalectomy.
Not Eligible

You will not qualify if you...

  • Inability to comply with study procedures or follow-up.
  • Multivisceral resection beyond left adrenalectomy.
  • History of previous pancreatic surgeries.
  • Expected lack of compliance with the study protocol.
  • Participation in another trial that may interfere with the intervention or outcomes of this study.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital Heidelberg

Heidelberg, Baden-Wurttemberg, Germany, 69120

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Study of Indocyanine Green Tracer in 3D Plus Ultra High Reso...

Gastric Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here